Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Current President & CEO Peter Bains will step down on 31 December 2018. He will also resign as a director of the Company simultaneously. Tamura, currently executive chairman, will become chairman ...

Bains described FY25 as a year of consolidation for the biosimilars business. And with the expansion of Biocon's vertically integrated model into new geographies, he also anticipates the drugmaker ...

It will also provide clients, access to collective service capability of multiple geographic sites, scientists and experience,” said Peter Bains, CEO Designate, Syngene International Ltd. The ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer (a key managerial personnel), effective from 1 April 2025, ...